NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine ...

Commitment to sustainability – from financing green and blue bonds, to creating digital access for customers, to maintaining transparent governance for all stakeholders – can enable banks to create a ...

NEW ORLEANS, LA—A single subcutaneous injection of a novel, small-molecule glycoprotein IIb/IIIa inhibitor administered at first medical contact in patients with suspected STEMI improves the patency ...

The National Bank of Ukraine (NBU) has imposed a corrective measure on MP and fifth President of Ukraine Petro Poroshenko, temporarily suspending his voting rights for 64.98292% of shares in the ...

Nello Mainolfi, Co-Founder, President, and CEO, stated that "our team has executed exceptionally well across all parts of our business," highlighting the company's focus on building a "global ...

EXN407 is the first topical SRPK1 inhibitor to demonstrate safety and efficacy as a monotherapy for non-proliferative diabetic retinopathy (NPDR) and diabetic macular oedema Phase IIb trial to ...

LONDON, United Kingdom, July 19, 2025 (EZ Newswire) -- iib East Africa, opens new tab has earned international recognition for its leadership in sustainable banking, securing three prestigious awards ...

Even though much is known about biomarkers, genetic risk loci, phenotypes, and corresponding endotypes in CSU, they’re usually considered independently. By establishing connectivity between these ...

The strategy of taking aim at IL-4Ra (type I and II receptors) and IL-31 by way of a bispecific antibody in atopic dermatitis (AD) has not worked out as well as Johnson & Johnson (J&J) hoped when, ...

Robbie has been an avid gamer for well over 20 years. During that time, he's watched countless franchises rise and fall. He's a big RPG fan but dabbles in a little bit of everything. Writing about ...